Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1480-1488

  Thomas, David L ^a   Villano, Stephen A ^b   Riester, Katherine A ^b   Hershow, Ronald ^b   Mofenson, Lynne M ^b   Landesman, Sheldon H ^b   Blaine Hollinger, F ^b   Davenny, Katherine ^b   Riley, Laura ^b   Diaz, Clemente ^b   Tang, Hope Babette ^b   Quinn, Thomas C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; NEWBORN; PERINATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 17344364927     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515315     Document Type: Article

References (16)

1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
3. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-6.
4. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
5. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon-α therapy for chronic hepatitis C. N Engl J Med 1989;321:1506-10.
6. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon-α. N Engl J Med 1989;321:1501-6.
7. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon-α2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
8. Roudot Thoraval F, Pawlotsky JM, Thiers V, et al. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 1993;17:772-7.
9. Reinus JF, Leikin EL, Alter HJ, et al. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 1992;117:881-6.
10. Ohio H, Terazawa S, Nobuhiko S, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
11. Zanetti AR, Tanzi E, Paccagnini S. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995;345:289-91.
12. Lam JPH, McOmish F, Bums SM, Yap PL, Mok JYQ, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993;167:572-6.
13. Novati R, Thiers V, Monforte AD, et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 1992;165:720-3.
14. Wejstal R, Widell A, Mansson A, Hermodsson S, Norkrans G. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 1992;117:887-90.
15. Weintrub PS, Veereman Wauters G, Cowan MJ, Thaler MM. Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 1991;119:869-74.
16. Manzini P, Saracco G, Cerchier A, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995;21:328-32.